Skip to main content
Top
Published in: Diabetologia 2/2007

01-02-2007 | Article

Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity

Authors: C. M. García-Herrero, M. Galán, O. Vincent, B. Flández, M. Gargallo, E. Delgado-Alvarez, E. Blázquez, M. A. Navas

Published in: Diabetologia | Issue 2/2007

Login to get access

Abstract

Aims/hypothesis

Glucokinase (GCK) acts as a glucose sensor in the pancreatic beta cell and regulates insulin secretion. In the gene encoding GCK the heterozygous mutations that result in enzyme inactivation cause MODY2. Functional studies of naturally occurring GCK mutations associated with hyperglycaemia provide further insight into the biochemical basis of glucose sensor regulation.

Materials and methods

Identification of GCK mutations in selected MODY patients was performed by single-strand conformation polymorphism and direct sequencing. The kinetic parameters and thermal stability of recombinant mutant human GCK were determined, and in pull-down assays the effect of these mutations on the association of GCK with glucokinase (hexokinase 4) regulator (GCKR, also known as glucokinase regulatory protein [GKRP]) and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB1, also known as PFK2) was tested.

Results

We identified three novel GCK mutations: the insertion of an asparagine residue at position 161 (inserN161) and two missense mutations (M235V and R308W). We also identified a fourth mutation (R397L) reported in a previous work. Functional characterisation of these mutations revealed that insertion of asparagine residue N161 fully inactivates GCK, whereas the M235V and R308W mutations only partially impair enzymatic activity. In contrast, GCK kinetics was almost unaffected by the R397L mutation. Although none of these mutations affected the interaction of GCK with PFKFB1, we found that the R308W mutation caused protein instability and increased the strength of interaction with GCKR.

Conclusions/interpretation

Our results show that different MODY2 mutations impair GCK function through different mechanisms such as enzymatic activity, protein stability and increased interaction with GCKR, helping further elucidate the regulation of GCK activity.
Literature
1.
go back to reference Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980PubMedCrossRef Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980PubMedCrossRef
2.
go back to reference Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F (2000) MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”? Diabetologia 43:1331–1332PubMedCrossRef Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F (2000) MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”? Diabetologia 43:1331–1332PubMedCrossRef
3.
go back to reference Pearson ER, Velho G, Clark P et al (2001) Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 50:S101–S107PubMedCrossRef Pearson ER, Velho G, Clark P et al (2001) Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 50:S101–S107PubMedCrossRef
4.
go back to reference Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39:647–652PubMedCrossRef Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39:647–652PubMedCrossRef
5.
go back to reference Zelent D, Najafi H, Odili S et al (2005) Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans 33:306–310PubMedCrossRef Zelent D, Najafi H, Odili S et al (2005) Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans 33:306–310PubMedCrossRef
6.
go back to reference Matschinsky FM (2005) Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep 5:171–176PubMedCrossRef Matschinsky FM (2005) Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep 5:171–176PubMedCrossRef
7.
go back to reference Van Schaftingen E, Detheux M, Veiga da Cunha M (1994) Short-term control of glucokinase activity: role of a regulatory protein. FASEB J 8:414–419PubMed Van Schaftingen E, Detheux M, Veiga da Cunha M (1994) Short-term control of glucokinase activity: role of a regulatory protein. FASEB J 8:414–419PubMed
8.
go back to reference Shiota C, Coffey J, Grimsby J, Grippo JF, Magnuson MA (1999) Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase. J Biol Chem 274:37125–37130PubMedCrossRef Shiota C, Coffey J, Grimsby J, Grippo JF, Magnuson MA (1999) Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase. J Biol Chem 274:37125–37130PubMedCrossRef
9.
go back to reference Alvarez E, Roncero I, Chowen JA, Vazquez P, Blazquez E (2002) Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem 80:45–53PubMedCrossRef Alvarez E, Roncero I, Chowen JA, Vazquez P, Blazquez E (2002) Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem 80:45–53PubMedCrossRef
10.
go back to reference Baltrusch S, Lenzen S, Okar DA, Lange AJ, Tiedge M (2001) Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner. J Biol Chem 276:43915–43923CrossRef Baltrusch S, Lenzen S, Okar DA, Lange AJ, Tiedge M (2001) Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner. J Biol Chem 276:43915–43923CrossRef
11.
go back to reference Massa L, Baltrusch S, Okar DA, Lange AJ, Lenzen S, Tiedge M (2004) Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells. Diabetes 53:1020–1029PubMedCrossRef Massa L, Baltrusch S, Okar DA, Lange AJ, Lenzen S, Tiedge M (2004) Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells. Diabetes 53:1020–1029PubMedCrossRef
12.
go back to reference Munoz-Alonso MJ, Guillemain G, Kassis N, Girard J, Burnol AF, Leturque A (2000) A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate. J Biol Chem 275:32406–32412PubMedCrossRef Munoz-Alonso MJ, Guillemain G, Kassis N, Girard J, Burnol AF, Leturque A (2000) A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate. J Biol Chem 275:32406–32412PubMedCrossRef
13.
go back to reference Rizzo MA, Piston DW (2003) Regulation of {beta} cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161:243–248PubMedCrossRef Rizzo MA, Piston DW (2003) Regulation of {beta} cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161:243–248PubMedCrossRef
14.
go back to reference Danial NN, Gramm CF, Scorrano L et al (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424:952–956PubMedCrossRef Danial NN, Gramm CF, Scorrano L et al (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424:952–956PubMedCrossRef
15.
go back to reference Shiraishi A, Yamada Y, Tsuura Y et al (2001) A novel glucokinase regulator in pancreatic beta cells precursor of propionyl-CoA carboxylase beta subunit interacts with glucokinase and augments its activity. J Biol Chem 276:2325–2328PubMedCrossRef Shiraishi A, Yamada Y, Tsuura Y et al (2001) A novel glucokinase regulator in pancreatic beta cells precursor of propionyl-CoA carboxylase beta subunit interacts with glucokinase and augments its activity. J Biol Chem 276:2325–2328PubMedCrossRef
16.
go back to reference Davis EA, Cuesta-Munoz A, Raoul M et al (1999) Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 42:1175–1186PubMedCrossRef Davis EA, Cuesta-Munoz A, Raoul M et al (1999) Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 42:1175–1186PubMedCrossRef
17.
go back to reference Kesavan P, Wang L, Davis E et al (1997) Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochem J 322:57–63PubMed Kesavan P, Wang L, Davis E et al (1997) Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochem J 322:57–63PubMed
18.
go back to reference Gloyn AL, Odili S, Zelent D et al (2005) Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem 280:14105–14113PubMedCrossRef Gloyn AL, Odili S, Zelent D et al (2005) Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem 280:14105–14113PubMedCrossRef
19.
go back to reference Galan M, Vincent O, Roncero I et al (2006) Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability. Biochem J 393:389–396PubMedCrossRef Galan M, Vincent O, Roncero I et al (2006) Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability. Biochem J 393:389–396PubMedCrossRef
20.
go back to reference Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL (2005) Permanent neonatal diabetes in an Asian infant. J Pediatr 146:131–133PubMedCrossRef Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL (2005) Permanent neonatal diabetes in an Asian infant. J Pediatr 146:131–133PubMedCrossRef
21.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
22.
go back to reference Stoffel M, Froguel P, Takeda J et al (1992) Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci USA 89:7698–7702PubMedCrossRef Stoffel M, Froguel P, Takeda J et al (1992) Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci USA 89:7698–7702PubMedCrossRef
23.
go back to reference Navas MA, Vaisse C, Boger S, Heimesaat M, Kollee LA, Stoffel M (2000) The human HNF-3 genes: cloning, partial sequence and mutation screening in patients with impaired glucose homeostasis. Hum Hered 50:370–381PubMedCrossRef Navas MA, Vaisse C, Boger S, Heimesaat M, Kollee LA, Stoffel M (2000) The human HNF-3 genes: cloning, partial sequence and mutation screening in patients with impaired glucose homeostasis. Hum Hered 50:370–381PubMedCrossRef
24.
go back to reference Liang Y, Kesavan P, Wang LQ et al (1995) Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J 309:167–173PubMed Liang Y, Kesavan P, Wang LQ et al (1995) Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J 309:167–173PubMed
25.
go back to reference Perez JX, Roig T, Manzano A et al (2000) Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am J Physiol Cell Physiol 279:C1359–C1365PubMed Perez JX, Roig T, Manzano A et al (2000) Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am J Physiol Cell Physiol 279:C1359–C1365PubMed
26.
go back to reference Rose MD, Winston F, Hieter P (1990) Methods in yeast genetics: a laboratory course manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY Rose MD, Winston F, Hieter P (1990) Methods in yeast genetics: a laboratory course manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
27.
go back to reference Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbour Laboratory, Cold Spring Harbor, NY Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbour Laboratory, Cold Spring Harbor, NY
28.
go back to reference Veiga-da-Cunha M, Xu LZ, Lee YH, Marotta D, Pilkis SJ, Van Schaftingen E (1996) Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia 39:1173–1179PubMedCrossRef Veiga-da-Cunha M, Xu LZ, Lee YH, Marotta D, Pilkis SJ, Van Schaftingen E (1996) Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia 39:1173–1179PubMedCrossRef
29.
go back to reference Gloyn AL, Odili S, Buetter C, Njolstad PR, Shiota C, Magnuson MA, Matschinsky FM (2004) Glucokinase and the regulation of blood sugar. A mathematical model predicts the threshold for glucose stimulated insulin release for GCK gene mutations that cause hyper- and hypoglycemia. In: Matschinsky FM, Magnuson MA (eds) Glucokinase and glycemic disease: from basics to novel therapeutics. Front. Diabetes. Vol 16, Karger, Basel, Switzerland, pp 92–109CrossRef Gloyn AL, Odili S, Buetter C, Njolstad PR, Shiota C, Magnuson MA, Matschinsky FM (2004) Glucokinase and the regulation of blood sugar. A mathematical model predicts the threshold for glucose stimulated insulin release for GCK gene mutations that cause hyper- and hypoglycemia. In: Matschinsky FM, Magnuson MA (eds) Glucokinase and glycemic disease: from basics to novel therapeutics. Front. Diabetes. Vol 16, Karger, Basel, Switzerland, pp 92–109CrossRef
30.
go back to reference Kamata K, Mitsuya M, Nishimura T, Eiki J, Nagata Y (2004) Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure 12:429–438PubMedCrossRef Kamata K, Mitsuya M, Nishimura T, Eiki J, Nagata Y (2004) Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure 12:429–438PubMedCrossRef
31.
go back to reference Sagen JV, Odili S, Bjorkhaug L et al (2006) From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes 55:1713–1722PubMedCrossRef Sagen JV, Odili S, Bjorkhaug L et al (2006) From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes 55:1713–1722PubMedCrossRef
32.
go back to reference Payne VA, Arden C, Wu C, Lange AJ, Agius L (2005) Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes. Diabetes 54:1949–1957PubMedCrossRef Payne VA, Arden C, Wu C, Lange AJ, Agius L (2005) Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes. Diabetes 54:1949–1957PubMedCrossRef
33.
go back to reference Gidh-Jain M, Takeda J, Xu LZ et al (1993) Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci USA 90:1932–1936PubMedCrossRef Gidh-Jain M, Takeda J, Xu LZ et al (1993) Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci USA 90:1932–1936PubMedCrossRef
34.
go back to reference Veiga-da-Cunha M, Courtois S, Michel A, Gosselain E, Van Schaftingen E (1996) Amino acid conservation in animal glucokinases. J Biol Chem 271:6292–6297PubMedCrossRef Veiga-da-Cunha M, Courtois S, Michel A, Gosselain E, Van Schaftingen E (1996) Amino acid conservation in animal glucokinases. J Biol Chem 271:6292–6297PubMedCrossRef
35.
go back to reference Baltrusch S, Francini F, Lenzen S, Tiedge M (2005) Interaction of glucokinase with the liver regulatory protein is conferred by leucine-asparagine motifs of the enzyme. Diabetes 54:2829–2837PubMedCrossRef Baltrusch S, Francini F, Lenzen S, Tiedge M (2005) Interaction of glucokinase with the liver regulatory protein is conferred by leucine-asparagine motifs of the enzyme. Diabetes 54:2829–2837PubMedCrossRef
36.
go back to reference Sayle RA, Milner-White EJ (1995) RASMOL: biomolecular graphics for all. Trends Biochem Sci 20:374–376PubMedCrossRef Sayle RA, Milner-White EJ (1995) RASMOL: biomolecular graphics for all. Trends Biochem Sci 20:374–376PubMedCrossRef
Metadata
Title
Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity
Authors
C. M. García-Herrero
M. Galán
O. Vincent
B. Flández
M. Gargallo
E. Delgado-Alvarez
E. Blázquez
M. A. Navas
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0542-7

Other articles of this Issue 2/2007

Diabetologia 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.